Board of Directors
G. John Zhang, Ph.D. is a co-founder of DOBI Global and becomes the Chairman of DOBI board in June 2010. Dr. Zhang has worked on management of development in technology and innovation as an entrepreneur for over fifteen years, and was executive of business, marketing and sales in several IPO companies from 2005 to 2010. From March to August of 2008, as managing director of Asia-Pacific Business Development at Implant Sciences, he generated over $7 millions' sales. Since 1994, Dr. Zhang had served in Boston Instruments as President to manage the company, and taken the responsibility on planning, organizing, directing and controlling of company's projects. He had successfully transferred Diffuse Optical Tomography and Magnetic Resonance Imaging technologies to product prototypes by leading technical teams. Dr. Zhang received his doctoral degree from the School of Engineering at MIT, two Masters of Science from University of Connecticut and the Graduate School of Academia Sinica and BS at Tsinghua University. In additional, he had an entrepreneurial training from Sloan School of Management at MIT and obtains the wealth of experience on engineering.
Lei Zhao, Ph.D. is a co-founder of DOBI Global and becomes a member of DOBI board in June 2010. Dr. Zhao serves as the Chairman of Symbow Medical and a board member of XinAoMDT, and had been appointed as Assistant Professor at Harvard Medical School and Physicist at Brigham and Women’s Hospital. Dr. Zhao is an expert of digital medical technology & clinical application, and received his doctoral degree from Boston University and Harvard University, and two bachelor degrees in biomedical engineering and BS in electrical engineering separately at Tsinghua University. Dr. Lei Zhao has published over 50 papers, one book chapter and owns two US patents and one Chinese patent. He has more than 10 years experience in field of the digital medical technology development. Dr. Zhao has a broad range of research interests including fast MR imaging, real-time acquisition, 3D high resolution imaging, hyperpolarized noble gas MRI, image guided therapy and digital medical IT. All of them are in leading position in the world.
Weiping Wang, Ph.D. is a
co-founder of DOBI Global and becomes a member of DOBI board in June
2010. Dr. Weiping Wang is a board member of Symbow Medical and was the
President of Symbow Medical. Dr. Wang has over fifteen years experience
in product development and project management for working with large
multi national companies and China Joint Venture in the field of
Robotics, Laser machines, Transportation monitoring devices,
Semiconductor systems automation, and Medical devices. Dr. Wang holds
over 10 US and Chinese patents. The breast cancer system Dr. Wang
designed, developed and trialed is honored as a World Leading
Technology& in China, a Silver Award for its patent was achieved, and
a national funds for Key Biomedical Research was granted by Chinese
National Hi-Tech Program. Dr. Wang obtained his Ph.D from University of